Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

The biotech investment landscape is experiencing an extraordinary transformation, with record amounts of capital flowing into medical research that promises to reshape healthcare as we know it. This ...

New York, NY -- The Conference Forum is pleased to announce the agenda and keynote speakers for the 13th annual Chief Medical Officer Summit 360°, the only conference dedicated to supporting the role ...

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

Australian pharmaceutical and biotechnology start-ups are ­already looking to take their investments to jurisdictions ...

The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...

Dr. Eva Cramer, Vice President of Research and Scientific Affairs at SUNY Downstate Medical, in ImClone System's laboratory. ImClone is the anchor tenant in Downstate's Advanced Biotechnology Park, ...

Fidelity Select Health Care Portfolio (FSPHX) delivers diversified growth across healthcare sectors, Vanguard Health Care Fund (VGHCX) combines global exposure with stability and T. Rowe Price Health ...

The biotech industry’s long-term expansion is fueled by increasing medical needs globally, favorable government support, and technological advances. Given the industry’s rosy outlook, quality biotech ...

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell ...